Biomm SA
BOVESPA:BIOM3

Watchlist Manager

Biomm SA

BOVESPA:BIOM3

Watchlist

Dividends

Discount Rate

Price: 8.79 BRL -2.66% Market Closed

Market Cap: 1.1B BRL

Have any thoughts about
Biomm SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 8.79 BRL

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

BIOM3 Alert

Biomm SA

8.79

-0.24 (-2.66%)

52 Week Range	5.1 20.19
Price Target

We'll email you a reminder when the closing price reaches BRL.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Biomm SA

What unique competitive advantages
does Biomm SA hold over its rivals?

What risks and challenges
does Biomm SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Biomm SA.

What unique competitive advantages
does Biomm SA hold over its rivals?

What risks and challenges
does Biomm SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biomm SA.

Provide P/S
for Biomm SA.

Provide P/E
for Biomm SA.

Provide P/OCF
for Biomm SA.

Provide P/FCFE
for Biomm SA.

Provide P/B
for Biomm SA.

Provide EV/S
for Biomm SA.

Provide EV/GP
for Biomm SA.

Provide EV/EBITDA
for Biomm SA.

Provide EV/EBIT
for Biomm SA.

Provide EV/OCF
for Biomm SA.

Provide EV/FCFF
for Biomm SA.

Provide EV/IC
for Biomm SA.

Compare the intrinsic valuations
of Biomm SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biomm SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biomm SA compared to its peers.

Compare the P/E ratios
of Biomm SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Biomm SA with its peers.

Analyze the financial leverage
of Biomm SA compared to its main competitors.

Show all profitability ratios
for Biomm SA.

Provide ROE
for Biomm SA.

Provide ROA
for Biomm SA.

Provide ROIC
for Biomm SA.

Provide ROCE
for Biomm SA.

Provide Gross Margin
for Biomm SA.

Provide Operating Margin
for Biomm SA.

Provide Net Margin
for Biomm SA.

Provide FCF Margin
for Biomm SA.

Show all solvency ratios
for Biomm SA.

Provide D/E Ratio
for Biomm SA.

Provide D/A Ratio
for Biomm SA.

Provide Interest Coverage Ratio
for Biomm SA.

Provide Altman Z-Score Ratio
for Biomm SA.

Provide Quick Ratio
for Biomm SA.

Provide Current Ratio
for Biomm SA.

Provide Cash Ratio
for Biomm SA.

What is the historical Revenue growth
over the last 5 years for Biomm SA?

What is the historical Net Income growth
over the last 5 years for Biomm SA?

What is the current Free Cash Flow
of Biomm SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biomm SA.

P/B
Price to Book Value

3.7

Current

Median

2.5

Industry

Lower than median

Higher than industry value

Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.

P/B

3.7

Market Cap

1.1B BRL

Book Value of Equity

304.7m BRL

All Countries

Forward Multiples

			Market Cap	P/B
BR		Biomm SA BOVESPA:BIOM3	1.1B BRL	3.7
FR		Pharnext SCA OTC:PNEXF	6T USD	-186 195.9
US		Abbvie Inc NYSE:ABBV	312.7B USD	51.8
US		Amgen Inc NASDAQ:AMGN	158.3B USD	21
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	116.2B USD	7.4
US		Gilead Sciences Inc NASDAQ:GILD	112.4B USD	6.1
US	E	Epizyme Inc F:EPE	94.1B EUR	-4 835
AU		CSL Ltd ASX:CSL	133.6B AUD	5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	81.3B USD	2.8
US	S	Seagen Inc F:SGT	39.3B EUR	16.1
NL		argenx SE XBRU:ARGX	34.8B EUR	8.5


BR		Biomm SA BOVESPA:BIOM3	Average P/B: 13.6 3.7
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -186 195.9
US		Abbvie Inc NYSE:ABBV	51.8
US		Amgen Inc NASDAQ:AMGN	21
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	7.4
US		Gilead Sciences Inc NASDAQ:GILD	6.1
US	E	Epizyme Inc F:EPE	Negative Multiple: -4 835
AU		CSL Ltd ASX:CSL	5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	2.8
US	S	Seagen Inc F:SGT	16.1
NL		argenx SE XBRU:ARGX	8.5

P/B Forward Multiples

Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/B

N/A

2-Years Forward

P/B

N/A

3-Years Forward

P/B

N/A

Biomm SA
BOVESPA:BIOM3

P/B
Price to Book Value

P/B Forward Multiples

See Also

Company

Help

Tools

Stocks

Biomm SA BOVESPA:BIOM3

P/B Price to Book Value

P/B Forward Multiples

See Also

Company

Help

Tools

Stocks

Biomm SA
BOVESPA:BIOM3

P/B
Price to Book Value